Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?

Research output: Contribution to journal › Review article › peer-review

455 Scopus citations

Access to Document

@article{d9ca57d2a4614a94bf695625428fa6ce,

title = "Histone deacetylase inhibitors in cancer therapy: Is transcription the primary target?",

author = "Johnstone, \{Ricky W.\} and Licht, \{Jonathan D.\}",

year = "2003",

month = jul,

day = "1",

doi = "10.1016/S1535-6108(03)00165-X",

language = "English",

volume = "4",

pages = "13--18",

journal = "Cancer Cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "1",

}

TY - JOUR

T1 - Histone deacetylase inhibitors in cancer therapy

T2 - Is transcription the primary target?

AU - Johnstone, Ricky W.

AU - Licht, Jonathan D.

PY - 2003/7/1

Y1 - 2003/7/1

UR - https://www.scopus.com/pages/publications/0041347519

U2 - 10.1016/S1535-6108(03)00165-X

DO - 10.1016/S1535-6108(03)00165-X

M3 - Review article

C2 - 12892709

AN - SCOPUS:0041347519

SN - 1535-6108

VL - 4

SP - 13

EP - 18

JO - Cancer Cell

JF - Cancer Cell

IS - 1

ER -